References
1. Mullol J, Alobid I, Mariño-Sánchez F, Quintó L, de Haro J,
Bernal-Sprekelsen M, et al. Furthering the understanding of olfaction,
prevalence of loss of smell and risk factors: a population-based survey
(OLFACAT study). BMJ Open. 2012;2(6).
2. Damm M, Temmel A, Welge-Lüssen A, Eckel HE, Kreft MP, Klussmann JP,
et al. [Olfactory dysfunctions. Epidemiology and therapy in Germany,
Austria and Switzerland]. HNO. 2004 Feb;52(2):112-20.
3. Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, et al.
More than just smell - COVID-19 is associated with severe impairment of
smell, taste, and chemesthesis. medRxiv. 2020:2020.05.04.20090902.
4. Philpott C. Coronavirus: loss of smell and taste reported as early
symptoms of COVID-19. The Conversation. 2020.
5. McNeill E, Ramakrishnan Y, Carrie S. Diagnosis and management of
olfactory disorders: survey of UK-based consultants and literature
review. J Laryngol Otol. 2007 Aug;121(8):713-20.
6. Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM,
et al. Position paper on olfactory dysfunction. Rhinology. 2017 Jun 17.
7. Hopkins C, Alanin M, Philpott C, Harries P, Whitcroft K, Qureishi A,
et al. Management of new onset loss of sense of smell during the
COVID-19 pandemic - BRS Consensus Guidelines. Clin Otolaryngol. 2020
Aug.
8. Philpott CM, Boak D. The impact of olfactory disorders in the United
kingdom. Chem Senses. 2014 Oct;39(8):711-8.
9. Erskine SE, Philpott CM. An unmet need: Patients with smell and taste
disorders. Clin Otolaryngol. 2020 Mar;45(2):197-203.
10. Addison A, Philpott CM. A systematic review of therapeutic options
for non-conductive olfactory dysfunction. The Otorhinolarnyngologist.
2018;11(2):61-71.
11. Hummel T, Whitcroft KL, Rueter G, Haehner A. Intranasal vitamin A is
beneficial in post-infectious olfactory loss. Eur Arch Otorhinolaryngol.
2017 Jul;274(7):2819-25.
12. Philpott CM. Smell and Taste Disorders in the UK: First experiences
with a specialised smell and taste outpatient clinic. Bulletin of the
Royal College of Surgeons of England. 2014;96:156-59.
13. Ball S, Boak D, Dixon J, Carrie S, Philpott C. Barriers to accessing
healthcare in patients with olfactory and gustatory disorders. Authorea.
2020.
14. Langstaff L, Pradhan N, Clark A, Boak D, Salam M, Hummel T, et al.
Validation of the olfactory disorders questionnaire for English-speaking
patients with olfactory disorders. Clin Otolaryngol. 2019
Sep;44(5):715-28.
15. Moran DT, Jafek BW, Eller PM, Rowley JC. Ultrastructural
histopathology of human olfactory dysfunction. Microsc Res Tech. 1992
Oct;23(2):103-10.
16. Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline
treatment of hyposmia and hypogeusia: a pilot study. Arch Otolaryngol
Head Neck Surg. 2012 Nov;138(11):1064-70.
17. Whitcroft KL, Merkonidis C, Cuevas M, Haehner A, Philpott C, Hummel
T. Intranasal sodium citrate solution improves olfaction in post-viral
hyposmia. Rhinology. 2016;54:368-74.
18. Philpott CM, Erskine SE, Clark A, Leeper A, Salam M, Sharma R, et
al. A randomised controlled trial of sodium citrate spray for
non-conductive olfactory disorders. Clin Otolaryngol. 2017
Dec;42(6):1295-302.
19. Whitcroft KL, Ezzat M, Cuevas M, Andrews P, Hummel T. The effect of
intranasal sodium citrate on olfaction in post-infectious loss: results
from a prospective, placebo-controlled trial in 49 patients. Clin
Otolaryngol. 2017 Jun;42(3):557-63.